Firefly Neuroscience (NASDAQ:AIFF – Get Free Report) and WM Technology (NASDAQ:MAPS – Get Free Report) are both small-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, profitability, risk, earnings and dividends.
Analyst Ratings
This is a summary of current ratings and price targets for Firefly Neuroscience and WM Technology, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Firefly Neuroscience | 1 | 0 | 0 | 0 | 1.00 |
| WM Technology | 1 | 0 | 1 | 0 | 2.00 |
WM Technology has a consensus target price of $2.61, suggesting a potential upside of 216.36%. Given WM Technology’s stronger consensus rating and higher possible upside, analysts plainly believe WM Technology is more favorable than Firefly Neuroscience.
Insider & Institutional Ownership
Profitability
This table compares Firefly Neuroscience and WM Technology’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Firefly Neuroscience | -2,705.88% | -319.00% | -191.27% |
| WM Technology | 4.40% | 6.22% | 4.22% |
Volatility & Risk
Firefly Neuroscience has a beta of 1.85, meaning that its stock price is 85% more volatile than the S&P 500. Comparatively, WM Technology has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500.
Valuation and Earnings
This table compares Firefly Neuroscience and WM Technology”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Firefly Neuroscience | $783,000.00 | 17.75 | -$10.46 million | ($2.09) | -0.49 |
| WM Technology | $184.51 million | 0.70 | $7.64 million | $0.07 | 11.79 |
WM Technology has higher revenue and earnings than Firefly Neuroscience. Firefly Neuroscience is trading at a lower price-to-earnings ratio than WM Technology, indicating that it is currently the more affordable of the two stocks.
Summary
WM Technology beats Firefly Neuroscience on 12 of the 14 factors compared between the two stocks.
About Firefly Neuroscience
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
About WM Technology
WM Technology, Inc. provides ecommerce and compliance software solutions to retailers and brands in cannabis market in the United States and internationally. The company offers Weedmaps marketplace that allows cannabis users to search for and browse cannabis products from retailers and brands, and reserve products from local retailers; and education and learning information to help newer consumers learn about the types of products to purchase. It also provides monthly subscription-based business software solutions, including WM Listings, WM Orders, WM Store, WM Connectors, and WM Insights as well as other add-on products, such as WM Ads, WM AdSuite, WM Customer Relationship Management, WM Dispatch, and WM Screens. WM Technology, Inc. was founded in 2008 and is headquartered in Irvine, California.
Receive News & Ratings for Firefly Neuroscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Firefly Neuroscience and related companies with MarketBeat.com's FREE daily email newsletter.
